Literature DB >> 16452181

The c-myc gene is a direct target of mammalian SWI/SNF-related complexes during differentiation-associated cell cycle arrest.

Norman G Nagl1, Daniel R Zweitzig, Bayar Thimmapaya, George R Beck, Elizabeth Moran.   

Abstract

The activity of mammalian SWI/SNF-related chromatin remodeling complexes is crucial for differentiation, development, and tumor suppression. Cell cycle-regulating activities dependent on the complexes include induction of the p21(WAF1/CIP1) kinase inhibitor and repression of E2F-responsive promoters. These responses are linked through effects on pRb phosphorylation, but the direct role of the SWI/SNF-related complexes in their regulation is not fully understood. Results presented here reveal that the complexes are required for regulation of a distinct pathway of proliferation control involving repression of c-myc expression in differentiating cells. This involves direct promoter targeting of the c-myc gene by the complexes. Induction of p21(WAF1/CIP1) is specifically dependent on prior repression of c-myc, but repression of E2F-responsive genes is dissociable from the regulation of c-myc and p21(WAF1/CIP1).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16452181     DOI: 10.1158/0008-5472.CAN-05-3427

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  64 in total

1.  Essential role of ARID2 protein-containing SWI/SNF complex in tissue-specific gene expression.

Authors:  Fuhua Xu; Stephen Flowers; Elizabeth Moran
Journal:  J Biol Chem       Date:  2011-12-19       Impact factor: 5.157

Review 2.  Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammation.

Authors:  Gerald V Denis
Journal:  Discov Med       Date:  2010-12       Impact factor: 2.970

3.  Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway.

Authors:  Zainab Jagani; E Lorena Mora-Blanco; Courtney G Sansam; Elizabeth S McKenna; Boris Wilson; Dongshu Chen; Justin Klekota; Pablo Tamayo; Phuong T L Nguyen; Michael Tolstorukov; Peter J Park; Yoon-Jae Cho; Kathy Hsiao; Silvia Buonamici; Scott L Pomeroy; Jill P Mesirov; Heinz Ruffner; Tewis Bouwmeester; Sarah J Luchansky; Joshua Murtie; Joseph F Kelleher; Markus Warmuth; William R Sellers; Charles W M Roberts; Marion Dorsch
Journal:  Nat Med       Date:  2010-11-14       Impact factor: 53.440

Review 4.  BET domain co-regulators in obesity, inflammation and cancer.

Authors:  Anna C Belkina; Gerald V Denis
Journal:  Nat Rev Cancer       Date:  2012-06-22       Impact factor: 60.716

5.  Lineage-specific activators affect beta-globin locus chromatin in multipotent hematopoietic progenitors.

Authors:  Stefania Bottardi; Julie Ross; Natacha Pierre-Charles; Volker Blank; Eric Milot
Journal:  EMBO J       Date:  2006-07-13       Impact factor: 11.598

6.  Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control.

Authors:  Norman G Nagl; Xiaomei Wang; Antonia Patsialou; Michael Van Scoy; Elizabeth Moran
Journal:  EMBO J       Date:  2007-01-25       Impact factor: 11.598

7.  ARID1A: a potential prognostic factor for breast cancer.

Authors:  Jing Zhao; Caigang Liu; Zuowei Zhao
Journal:  Tumour Biol       Date:  2014-01-16

8.  A novel strategy to dissect endogenous gene transcriptional regulation in live cells.

Authors:  Wenqing Yang; Siliang Zhang; Yi Zhang; Xin Huang
Journal:  Biochem Biophys Res Commun       Date:  2017-04-19       Impact factor: 3.575

9.  Human SWI/SNF drives sequence-directed repositioning of nucleosomes on C-myc promoter DNA minicircles.

Authors:  Hillel I Sims; Jacqueline M Lane; Natalia P Ulyanova; Gavin R Schnitzler
Journal:  Biochemistry       Date:  2007-09-18       Impact factor: 3.162

Review 10.  A rationale to target the SWI/SNF complex for cancer therapy.

Authors:  Anja F Hohmann; Christopher R Vakoc
Journal:  Trends Genet       Date:  2014-06-03       Impact factor: 11.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.